Ponoi Management, LLC

Ponoi Management, LLC has an estimated net worth of $729 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., CONSTELLATION PHARMACEUTICALS INC, Revolution Medicines, Inc., Nurix Therapeutics, Inc., Arcus Biosciences, Inc., RAPT Therapeutics, Inc., and NGM BIOPHARMACEUTICALS INC.

2019 was Ponoi Management, LLC's most active year for acquiring shares with 60 total transactions. Ponoi Management, LLC's most active month to acquire stocks was the month of April. 2021 was Ponoi Management, LLC's most active year for disposing of shares, totalling 58 transactions. Ponoi Management, LLC's most active month to dispose stocks was the month of August. 2019 saw Ponoi Management, LLC paying a total of $62,465,985.21 for 24,146,787 shares, this is the most they've acquired in one year. In 2020 Ponoi Management, LLC cashed out on 17,877,849 shares for a total of $104,799,656.90, their largest year based on trade value.